Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study

RECOMMENDED

Asthma

A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Respir Med

Menzella F, Cottini M, Lombardi C, Senna G, Chan R, Bosi A, Bortoli M, Tonin S, Corsi L, Rastelli A, Marchi MR

doi: 10.1016/j.rmed.2025.108054

COMMENTED

AsthmaFurther Publications

Cohort multiple randomized controlled trial in pediatric asthma to assess the long- and short-term effects of eHealth interventions: protocol of the CIRCUS study

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Ther Adv Respir Dis

Ruuls T, Sprengers R, Hengeveld V, Thio B, Tabak M, Zagers D, van der Palen J, van der Kamp M

doi: 10.1177/17534666251323192

Asthma

Sub-Optimal Disease Control and Low Blood Eosinophil Testing Frequency in Chinese Adult Patients with Asthma Receiving GINA Step 4/5 Treatment: A Real-World Study

J Asthma Allergy

Benson VS, Siddall J, Haq A, Small M, Tang Z, Ye T, Howarth P, Richards A, Alfonso-Cristancho R

doi: 10.2147/JAA.S474338

Asthma

Real-Life Effectiveness of Budesonide/Formoterol as Maintenance and Reliever Treatment via the Elpenhaler(®) Device in Patients with Asthma: The NOTOS Observational Study

J Asthma Allergy

Gogali A, Rovina N, Samitas K, Steiropoulos P, Potonos D, Bertoli M, Papanastasiou P, Ginis A, Kostikas K

doi: 10.2147/JAA.S517932

Asthma

Small Airways Disease as a Novel Target for Mepolizumab in Asthma-The SASAM Prospective Real-Life Study

J Clin Med

Bonini M, Boccabella C, Cefaloni F, De Corso E, Donfrancesco F, Schiavi E, Richeldi L

doi: 10.3390/jcm14092928

COMMENTED

Bronchi

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med

Sibila O, Stobo J, Perea L, Gao YH, Xu JF, Lind H, Viligorska K, Spinou A, Polverino E, Ringshausen FC, Vendrell M, Burgel PR, Haworth CS, Loebinger MR, Lorent N, Dhar R, Choi H, Chotirmall SH, De Soyza A, Hurst JR, Brown JS, van der Eerden M, Kauppi P, Johnson ED, Mendez R, Dimakou K, Bossios A, Torres A, Blasi F, Shteinberg M, Elborn SJ, Goeminne PC, Aliberti S, Jayaram L, Karalus N, Taylor SL, Martin ML, Burr LD, Wong C, Terpstra L, Altenburg J, Boersma W, Chalmers JD

doi: 10.1016/S2213-2600(25)00160-2

Asthma

Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler® and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study

Respir Med

Braido F, Beeh KM, Serrano CC, Dinh-Xuan AT, Tamási L, Trofor A, Ingrassia E, Piraino A, Caruso C, NEWTON study group

doi: 10.1016/j.rmed.2025.108224

RECOMMENDED

Asthma

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials

★ 3 Recommended by Dr Martin Frey, Faculty Member

Lancet Respir Med

Meulmeester FL, Mailhot-Larouche S, Celis-Preciado C, Lemaire-Paquette S, Ramakrishnan S, Wechsler ME, Brusselle G, Corren J, Hardy J, Diver SE, Brightling CE, Castro M, Hanania NA, Jackson DJ, Martin N, Laugerud A, Santoro E, Compton C, Hardin ME, Holweg CTJ, Subhashini A, Hinks TSC, Beasley RW, Sont JK, Steyerberg EW, Pavord ID, Couillard S

doi: 10.1016/S2213-2600(25)00037-2

Lung Cancer

Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study

Lancet Respir Med

Lu S, Vynnychenko O, Kulyaba Y, Kuchava V, Ibrahim A, Moiseenko F, Arslan C, Nguyen DT, Petrovic M, Cicin I, Bibichadze K, Cil T, Shi J, Olmez OF, Gogishvili M, Artac M, Nguyen HG, Cornfeld M, Tian C, Munteanu MC, Sette CVM, Bondarenko I, POD1UM-304 Study Team

doi: 10.1016/S2213-2600(25)00209-7

Related content

A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction

Cohort multiple randomized controlled trial in pediatric asthma to assess the long- and short-term effects of eHealth interventions: protocol of the CIRCUS study

Sub-Optimal Disease Control and Low Blood Eosinophil Testing Frequency in Chinese Adult Patients with Asthma Receiving GINA Step 4/5 Treatment: A Real-World Study

Real-Life Effectiveness of Budesonide/Formoterol as Maintenance and Reliever Treatment via the Elpenhaler(®) Device in Patients with Asthma: The NOTOS Observational Study

Small Airways Disease as a Novel Target for Mepolizumab in Asthma-The SASAM Prospective Real-Life Study

Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study

Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler® and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study

Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials

Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study